Drug
D0017 | Butacaine
| Organism | Test type | Route | Dose (normalized dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LDLo | subcutaneous | 50mg/kg (50mg/kg) | Journal of the American Chemical Society. Vol. 61, Pg. 3562, 1939. | |
| cat | LDLo | intravenous | 15mg/kg (15mg/kg) | American Journal of Physiology. Vol. 68, Pg. 110, 1924. | |
| mouse | LDLo | subcutaneous | 100mg/kg (100mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 24, Pg. 167, 1925. | |
| dog | LDLo | subcutaneous | 55mg/kg (55mg/kg) | Physiological Reviews. Vol. 12, Pg. 190, 1932. | |
| rat | LDLo | subcutaneous | 197mg/kg (197mg/kg) | Physiological Reviews. Vol. 12, Pg. 190, 1932. | |
| mouse | LDLo | intravenous | 12mg/kg (12mg/kg) | Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 39, Pg. 4, 1950. | |
| bird - wild | LD50 | oral | 100mg/kg (100mg/kg) | Toxicology and Applied Pharmacology. Vol. 21, Pg. 315, 1972. | |
| rabbit | LDLo | subcutaneous | 50mg/kg (50mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 24, Pg. 167, 1925. | |
| frog | LDLo | intraspinal | 30mg/kg (30mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 45, Pg. 291, 1932. | |
| guinea pig | LDLo | subcutaneous | 45mg/kg (45mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 62, Pg. 69, 1938. | |
| mouse | LD50 | intraperitoneal | 80mg/kg (80mg/kg) | British Journal of Pharmacology and Chemotherapy. Vol. 1, Pg. 90, 1946. | |
| rat | LDLo | intravenous | 7500ug/kg (7.5mg/kg) | Physiological Reviews. Vol. 12, Pg. 190, 1932. | |
| cat | LDLo | subcutaneous | 30mg/kg (30mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 24, Pg. 167, 1925. | |
| rabbit | LDLo | intravenous | 12mg/kg (12mg/kg) | Physiological Reviews. Vol. 12, Pg. 190, 1932. | |
| mouse | LD50 | intravenous | 12mg/kg (12mg/kg) | Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 40, Pg. 373, 1951. | |
| rat | LDLo | subcutaneous | 150mg/kg (150mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 24, Pg. 167, 1925. | |
| (3-di-N-Butylaminopropyl)-p-aminobenzoate | 1-PROPANOL, 3-(DIBUTYLAMINO)-, p-AMINOBENZOATE (ESTER) | 1-Propanol, 3-(dibutylamino)-, 1-(4-aminobenzoate) |
| 1-Propanol, 3-(dibutylamino)-, 4-aminobenzoate | 1-Propanol, 3-(dibutylamino)-, 4-aminobenzoate (ester) | 1-Propanol, 3-(dibutylamino)-, p-aminobenzoate |
| 149-16-6 | 2290AH | 3-(Dibutylamino)-1-propanol p-aminobenzoate |
| 3-(Dibutylamino)propyl 4-aminobenzoate | 3-(Dibutylamino)propyl 4-aminobenzoate # | 3-(p-Aminobenzoxy)-1-di-n-butylaminopropane |
| 3-Dibutylaminopropyl p-aminobenzoate | 4-aminobenzoic acid 3-(dibutylamino)propyl ester | AB00052382 |
| AB00052382_15 | AB00052382_16 | AKOS024374899 |
| API0015124 | BDBM50225491 | BPBio1_000861 |
| BRD-K99622919-001-05-7 | BRD-K99622919-001-15-6 | BRN 2135378 |
| BSPBio_000781 | BSPBio_003543 | Butacaina |
| Butacaina [INN-Spanish] | Butacaine [INN:BAN] | Butacaine sulphate |
| Butacainum | Butacainum [INN-Latin] | C18H30N2O2 |
| CAS-149-16-6 | CCG-39371 | CHEBI:94820 |
| CHEMBL129529 | CS-4504 | CTK8F8367 |
| DSSTox_CID_25300 | DSSTox_GSID_45300 | DSSTox_RID_80789 |
| DTXSID3045300 | DivK1c_000864 | EINECS 205-734-7 |
| HMS1570H03 | HMS1922K10 | HMS2093K17 |
| HMS2097H03 | HMS2230J20 | HMS3371O14 |
| HMS3714H03 | HMS502L06 | HQFWVSGBVLEQGA-UHFFFAOYSA-N |
| HY-B1007 | IDI1_000864 | J-008557 |
| J-008559 | KBio1_000864 | KBio2_002042 |
| KBio2_004610 | KBio2_007178 | KBio3_002827 |
| KBioGR_000857 | KBioSS_002042 | LS-122041 |
| MCULE-4554935124 | MLS000028619 | NCGC00016411-01 |
| NCGC00016411-02 | NCGC00016411-03 | NCGC00016411-04 |
| NCGC00016411-05 | NCGC00016411-06 | NCGC00016411-07 |
| NCGC00016411-10 | NCGC00023714-03 | NCGC00023714-04 |
| NCGC00023714-05 | NINDS_000864 | NSC-758632 |
| NSC758632 | Opera_ID_1473 | Pharmakon1600-01503914 |
| Prestwick0_000831 | Prestwick1_000831 | Prestwick2_000831 |
| Prestwick3_000831 | Prestwick_984 | Q5002339 |
| SBI-0051856.P002 | SCHEMBL26156 | SMR000058686 |
| SPBio_001586 | SPBio_002702 | SPECTRUM1503914 |
| SR-01000003139 | SR-01000003139-2 | SR-01000003139-3 |
| ST51014906 | SW197068-3 | Spectrum2_001593 |
| Spectrum3_001943 | Spectrum4_000219 | Spectrum5_001565 |
| Spectrum_001562 | Tox21_110428 | Tox21_110428_1 |
| UNII-Z84S23CGJJ | Z84S23CGJJ | ZINC1596184 |
| butacaine | p-Aminobenzoyldibutylaminopropanol |
1. Chan et al. (2005)